References
- 1Schmidt A, Neumann M, Writz M, Errnstmann N, Straatschek-Jok A, Stroelben E, et al. The influence of occupational stress factors on the nicotine dependence: a cross sectional study. Tob Induc Dis. 2010; 8:1-6.SchmidtANeumannMWritzMErrnstmannNStraatschek-JokAStroelbenEet alThe influence of occupational stress factors on the nicotine dependence: a cross sectional studyTob Induc Dis2010816
- 2Caporoso N, Gu F, Sheng-Chih J, Yu K, Yeager M, Chan C, et al. Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One. 2009; 4:e4653.10.1371/journal.pone.000465319247474CaporosoNGuFSheng-ChihJYuKYeagerMChanCet alGenome-wide and candidate gene association study of cigarette smoking behaviorsPLoS One20094e4653
- 3Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F et al. Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affecting smoking behavior. Nature Genetics. 2010; 42:448-53.10.1038/ng.573ThorgeirssonTEGudbjartssonDFSurakkaIVinkJMAminNGellerFet alSequence variants at CHRNB3–CHRNA6 and CYP2A6 affecting smoking behaviorNature Genetics20104244853
- 4Nelson DR, Koymans T, Stegeman JJ, Fey-ereisen R, Waxman DJ, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 1996; 6:1-42.10.1097/00008571-199602000-000028845856NelsonDRKoymansTStegemanJJFey-ereisenRWaxmanDJet alP450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics19966142
- 5Nakajima M, Yamamoto T, Nunoya KI, Yokoi T, Nagashima K, Inoue K, et al. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug metab Dispos. 1996; 24:1212-17.8937855NakajimaMYamamotoTNunoyaKIYokoiTNagashimaKInoueKet alRole of human cytochrome P4502A6 in C-oxidation of nicotineDrug metab Dispos199624121217
- 6Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, Tyndale RF. Impact of CYP2A6 genotype on pretreatment smoking behavior and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry. 2006; 11:400-9.10.1038/sj.mp.400179416402128MalaiyandiVLermanCBenowitzNLJepsonCPattersonFTyndaleRFImpact of CYP2A6 genotype on pretreatment smoking behavior and nicotine levels from and usage of nicotine replacement therapyMol Psychiatry2006114009
- 7Audrain-McGovern J, Koudsi NA, Rodriguez D, Wileyto EP, Shields PG. The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics. 2007; 119:e264-74.1713027910.1542/peds.2006-1583Audrain-McGovernJKoudsiNARodriguezDWileytoEPShieldsPGThe role of CYP2A6 in the emergence of nicotine dependence in adolescentsPediatrics2007119e26474
- 8Benowitz NL, Perez-Stable EL, Herrer B, Jacob P. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Natl Cancer Inst. 2002; 94:108-15.10.1093/jnci/94.2.10811792749BenowitzNLPerez-StableELHerrerBJacobPSlower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-AmericansJ Natl Cancer Inst20029410815
- 9Liu T, David S P, Tyndale RF, Wang H, Zhou Q, Ding P, et al. Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction. 2011; 106:985-94.10.1111/j.1360-0443.2010.03353.x21205058LiuTDavidS PTyndaleRFWangHZhouQDingPet alAssociations of CYP2A6 genotype with smoking behaviors in southern ChinaAddiction201110698594
- 10Moylan S, Jacka FN, Pasco JA, Berg M. Cigarette smoking, nicotine dependence and anxiety disorder: a systematic review of population-based, epidemiology studies. BMC Medicine. 2012; 10:123.2308345110.1186/1741-7015-10-123MoylanSJackaFNPascoJABergMCigarette smoking, nicotine dependence and anxiety disorder: a systematic review of population-based, epidemiology studiesBMC Medicine201210123
- 11Lawrence D, Considine J, Mitrou F, Zubrick S.R. Anxiety disorders and cigarette smoking: Results from the Australian Survey of Mental health and Wellbeing. Aust NZ Psychiatry. 2010; 44:520-7.LawrenceDConsidineJMitrouFZubrickS.R.Anxiety disorders and cigarette smoking: Results from the Australian Survey of Mental health and WellbeingAust NZ Psychiatry2010445207
- 12John U, Meyer C, Phil HR, Phil UH. Depressive disorders are related to nicotine dependence in the population but do not necessarily hamper smoking cessation. J Clin Psychiatry. 2004; 6:169-76.JohnUMeyerCPhilHRPhilUHDepressive disorders are related to nicotine dependence in the population but do not necessarily hamper smoking cessationJ Clin Psychiatry2004616976
- 13Jamal M, Willem Van Der Does AJ, Cuijpers P, Penninx BW. Association of smoking and nicotine dependence with severity and course of symptoms in patients with depressive or anxiety disorder. Drug Alcohol Depend. 2012; 126:138-46.10.1016/j.drugalcdep.2012.05.00122633368JamalMWillem Van Der DoesAJCuijpersPPenninxBWAssociation of smoking and nicotine dependence with severity and course of symptoms in patients with depressive or anxiety disorderDrug Alcohol Depend201212613846
- 14Goodwin RD, Zvolensky MJ, Keyes KM. Nicotine dependence and mental disorders among adults in the USA: Evaluating the role of the mode of administration. Psychol Med. 2008; 38:1277-86.18366824GoodwinRDZvolenskyMJKeyesKMNicotine dependence and mental disorders among adults in the USA: Evaluating the role of the mode of administrationPsychol Med200838127786
- 15Grover KW, Goodwin RD, Zvolensky MJ. Does current versus former smoking play role in the relationship between anxiety and mood disorders and nicotine dependence?. Addict Behav. 2012; 37:682-5.2234220310.1016/j.addbeh.2012.01.014GroverKWGoodwinRDZvolenskyMJDoes current versus former smoking play role in the relationship between anxiety and mood disorders and nicotine dependence?Addict Behav2012376825
- 16Weinberger AH, Desai RA, McKee SA. Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders. Drug Alcohol Depend. 2010; 108:7-12.10.1016/j.drugalcdep.2009.11.00420006451WeinbergerAHDesaiRAMcKeeSANicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disordersDrug Alcohol Depend2010108712
- 17Suttajit S, Kittirattanapaiboon P, Junsirimongkol B, Likhitsatian S, Srisurapanont M. Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drugs use: Finding from the 2008 Thai National Mental Health survey. Addict Behav. 2012; 37:1395-9.10.1016/j.addbeh.2012.06.014SuttajitSKittirattanapaiboonPJunsirimongkolBLikhitsatianS isurapanont M
Sr Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drugs use: Finding from the 2008 Thai National Mental Health surveyAddict Behav20123713959 - 18Brook JS, Saar N, Zhang C, Brook DA. Familial and nonfamilial smoking: effects on smoking and nicotine dependence. Drug Alcohol Depend. 2009; 101:62-8.10.1016/j.drugalcdep.2008.11.003BrookJSSaarNZhangCBrookDAFamilial and nonfamilial smoking: effects on smoking and nicotine dependenceDrug Alcohol Depend2009101628
- 19Tully EC, Iacono WG, McGue M. Changes in genetic and environmental influences on the development of nicotine dependence and major depressive disorder from middle adolescence to early adulthood. Dev Psychopathol. 2010; 22:831-48.10.1017/S095457941000049020883585TullyECIaconoWGMcGueMChanges in genetic and environmental influences on the development of nicotine dependence and major depressive disorder from middle adolescence to early adulthoodDev Psychopathol20102283148
- 20Heatherton TF, Kozlowski LT, Frecker RC, Fagerstr m KO. The Fagerstr m Test for Nicotine Dependence: a revision of the Fagerstr m Tolerance Questionnaire. Br J Addict. 1991; 86:1119-27.10.1111/j.1360-0443.1991.tb01879.xHeathertonTFKozlowskiLTFreckerRCFagerstrm KOThe Fagerstr m Test for Nicotine Dependence: a revision of the Fagerstr m Tolerance QuestionnaireBr J Addict199186111927
- 21Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF. Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. Addict Behav. 1994; 19:33-9.10.1016/0306-4603(94)90049-38197891PomerleauCSCartonSMLutzkeMLFlesslandKAPomerleauOFReliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine DependenceAddict Behav199419339
- 22Nilchaikovit T, Lotrakul M, Phisansuthideth U. Development of Thai version of Hospital anxiety and depression scale in cancer patients. J Thai Psych Assoc. 1996; 41:18-30.NilchaikovitTLotrakulMPhisansuthidethUDevelopment of Thai version of Hospital anxiety and depression scale in cancer patientsJ Thai Psych Assoc1996411830
- 23Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67: 361-70.10.1111/j.1600-0447.1983.tb09716.x6880820ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand19836736170
- 24Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. Psychosom Res. 2002; 52:69-77.10.1016/S0022-3999(01)00296-3BjellandIDahlAAHaugTTNeckelmannDThe validity of the hospital anxiety and depression scale. An updated literature reviewPsychosom Res2002526977
- 25Ariyoshi N, Takahashi Y, Miyamoto M, Umetsu Y, Daigo S, Tateishi T, et al. Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C. Pharmacogenetics. 2000; 10:687-93.1118613110.1097/00008571-200011000-00003AriyoshiNTakahashiYMiyamotoMUmetsuYDaigoSTateishiTet alStructural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4CPharmacogenetics20001068793
- 26Apinan R, Tassaneeyakul W, Satarug S, Kajanawart S, Vannaprasaht S, Ruenweerayut R, et al. The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population. Environ Toxicol Pharmacol. 2010; 28:420-24.ApinanRTassaneeyakulWSatarugSKajanawartSVannaprasahtSRuenweerayutRet alThe influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai populationEnviron Toxicol Pharmacol20102842024
- 27Mahavorasirikul W, Tassaneeyakul W, Satarug S, Ruengweerawut R, Na-bangchang C, Na-bangchang K. CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking. Eur J Clin Pharmacol. 2009; 65: 377-84.10.1007/s00228-008-0595-2MahavorasirikulWTassaneeyakulWSatarugSRuengweerawutRNa-bangchangCNa-bangchangKCYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smokingEur J Clin Pharmacol20096537784
- 28Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob III P. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther. 2006; 79: 480-88.1667854910.1016/j.clpt.2006.01.008BenowitzNLLessov-SchlaggarCNSwanGEJacobP
III Female sex and oral contraceptive use accelerate nicotine metabolismClin Pharmacol Ther20067948088 - 29Rubinstein ML, Benowitz NL, Auerback GM, Moscicki AB. Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers. Pediatrics. 2008; 122:e643-47.10.1542/peds.2007-367918762498RubinsteinMLBenowitzNLAuerbackGMMoscickiABRate of nicotine metabolism and withdrawal symptoms in adolescent light smokersPediatrics2008122e64347
- 30Fergusson DM, Horwood LJ, Boden JM, Jenkin G. Childhood social disadvantage and smoking in adulthood: results of a 25-year longitudinal study. Addiction. 2007; 102:475-82.10.1111/j.1360-0443.2006.01729.x17298656FergussonDMHorwoodLJBodenJMJenkinGChildhood social disadvantage and smoking in adulthood: results of a 25-year longitudinal studyAddiction200710247582
- 31Cuijpers P, Smit F, ten Have M, de Graaf R. Smoking is associated with first-ever incidence of mental disorders: a prospective population-based study. Addiction. 2007; 102:1303-9.10.1111/j.1360-0443.2007.01885.x17624980CuijpersPSmitFtenHave MdeGraaf RSmoking is associated with first-ever incidence of mental disorders: a prospective population-based studyAddiction200710213039